Application

AMTAGVI

Iovance Biotherapeutics, Inc.

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88918260
Filing Date: 05/15/020

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88918260
MARK INFORMATION
*MARK AMTAGVI
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT AMTAGVI
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Iovance Biotherapeutics, Inc.
*MAILING ADDRESS 999 Skyway Road Suite 150
*CITY San Carlos
*STATE
(Required for U.S. applicants)
California
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
94070
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations and biological preparations for the treatment of immune system related and oncological diseases and disorders; diagnostic preparations for medical use, namely, biological diagnostic preparations for medical use
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 044 
*IDENTIFICATION Medical treatment of cancer via the modification of cells; medical services, namely, medical services for the treatment of a wide range of diseases and medical conditions via the modification of cells; medical services in the field of immunotherapy treatments; medical diagnosis and treatment of immune system related diseases and disorders; medical services, namely, medical services for the diagnosis and treatment of a wide range of diseases and medical conditions; providing medical information relating to oncology and immunotherapy treatment; providing medical information; medical consultations; isolation, collection, and banking of human biological tissue for immunotherapy
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Carla B. Oakley
ATTORNEY DOCKET NUMBER 116983-2190
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Morgan, Lewis & Bockius LLP
STREET One Market, Spear Street Tower
CITY San Francisco
STATE California
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 94105
PHONE 415-442-1301
FAX 415-442-1001
EMAIL ADDRESS carla.oakley@morganlewis.com
OTHER APPOINTED ATTORNEY the firm of Morgan, Lewis & Bockius LLP, CARLA B. OAKLEY, ROCHELLE D. ALPERT, SHARON R. SMITH, GENE K. PARK, PETER BYRNE, and JENNA STOKES, members of the California Bar, all located at One Market, Spear Street Tower, San Francisco, California 94105, RON N. DREBEN, KAREN A. BUTCHER, ANITA B. POLOTT, CAROLE R. KLEIN, JOSEPH E. WASHINGTON, KRISTIN H. ALTOFF, DANA S. GROSS, JANE W. WISE, SETH A. RAPPAPORT, CONSTANCE BOUTSIKARIS, REBECCA E. MCDOUGALL, BRITTANY A. ESTELL, RACHEL FERTIG and KIRAN JASSAL, all located at 1111 Pennsylvania Ave., NW, Washington, D.C. 20004, ANDREW J. GRAY IV, member of the California Bar, located at 1400 Page Mill Road, Palo Alto, California 94304, and RACHELLE A. DUBOW, DAVID O. JOHANSON and AMELIA G. PENNINGTON, members of the Massachusetts Bar, all located at One Federal Street, Boston, Massachusetts 02110
CORRESPONDENCE INFORMATION
NAME Carla B. Oakley
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE carla.oakley@morganlewis.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) jenna.stokes@morganlewis.com; sftrademarks@morganlewis.com; thomas.loran@morganlewis.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 2
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEES DUE 550
*TOTAL FEES PAID 550
SIGNATURE INFORMATION
SIGNATURE /Carla B. Oakley/
SIGNATORY'S NAME Carla B. Oakley
SIGNATORY'S POSITION Attorney of Record, California Bar member
SIGNATORY'S PHONE NUMBER 415-442-1301
DATE SIGNED 05/15/2020



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 88918260
Filing Date: 05/15/020

To the Commissioner for Trademarks:

MARK: AMTAGVI (Standard Characters, see mark)
The literal element of the mark consists of AMTAGVI. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Iovance Biotherapeutics, Inc., a corporation of Delaware, having an address of
      999 Skyway Road Suite 150
      San Carlos, California 94070
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Pharmaceutical preparations and biological preparations for the treatment of immune system related and oncological diseases and disorders; diagnostic preparations for medical use, namely, biological diagnostic preparations for medical use
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 044:  Medical treatment of cancer via the modification of cells; medical services, namely, medical services for the treatment of a wide range of diseases and medical conditions via the modification of cells; medical services in the field of immunotherapy treatments; medical diagnosis and treatment of immune system related diseases and disorders; medical services, namely, medical services for the diagnosis and treatment of a wide range of diseases and medical conditions; providing medical information relating to oncology and immunotherapy treatment; providing medical information; medical consultations; isolation, collection, and banking of human biological tissue for immunotherapy
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The owner's/holder's proposed attorney information: Carla B. Oakley. Other appointed attorneys are the firm of Morgan, Lewis & Bockius LLP, CARLA B. OAKLEY, ROCHELLE D. ALPERT, SHARON R. SMITH, GENE K. PARK, PETER BYRNE, and JENNA STOKES, members of the California Bar, all located at One Market, Spear Street Tower, San Francisco, California 94105, RON N. DREBEN, KAREN A. BUTCHER, ANITA B. POLOTT, CAROLE R. KLEIN, JOSEPH E. WASHINGTON, KRISTIN H. ALTOFF, DANA S. GROSS, JANE W. WISE, SETH A. RAPPAPORT, CONSTANCE BOUTSIKARIS, REBECCA E. MCDOUGALL, BRITTANY A. ESTELL, RACHEL FERTIG and KIRAN JASSAL, all located at 1111 Pennsylvania Ave., NW, Washington, D.C. 20004, ANDREW J. GRAY IV, member of the California Bar, located at 1400 Page Mill Road, Palo Alto, California 94304, and RACHELLE A. DUBOW, DAVID O. JOHANSON and AMELIA G. PENNINGTON, members of the Massachusetts Bar, all located at One Federal Street, Boston, Massachusetts 02110. Carla B. Oakley of Morgan, Lewis & Bockius LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      One Market, Spear Street Tower
      San Francisco, California 94105
      United States
      415-442-1301(phone)
      415-442-1001(fax)
      carla.oakley@morganlewis.com
The docket/reference number is 116983-2190.
Carla B. Oakley submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
      Carla B. Oakley
       PRIMARY EMAIL FOR CORRESPONDENCE: carla.oakley@morganlewis.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): jenna.stokes@morganlewis.com; sftrademarks@morganlewis.com; thomas.loran@morganlewis.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $550 has been submitted with the application, representing payment for 2 class(es).

Declaration

Declaration Signature

Signature: /Carla B. Oakley/   Date: 05/15/2020
Signatory's Name: Carla B. Oakley
Signatory's Position: Attorney of Record, California Bar member
Payment Sale Number: 88918260
Payment Accounting Date: 05/15/2020

Serial Number: 88918260
Internet Transmission Date: Fri May 15 14:48:52 ET 2020
TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.XX-202005151448521
44523-88918260-7108aee9eab06ff24ff43f33a
1dff2e2b9f07264bb24c6e7aad35957ded751124
-DA-48519757-20200515125127604872

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed